1. Home
  2. RDY

as of 12-04-2025 3:44pm EST

$14.13
$0.00
0.00%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Chart Type:
Time Range:
Founded: 1984 Country:
India
India
Employees: N/A City: N/A
Market Cap: 11.6B IPO Year: N/A
Target Price: $16.90 AVG Volume (30 days): 923.2K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
0.50%
Dividend Payout Frequency: Annual
EPS: 0.79 EPS Growth: 9.95
52 Week Low/High: $12.26 - $16.17 Next Earning Date: 01-22-2026
Revenue: $3,851,623,984 Revenue Growth: 14.10%
Revenue Growth (this year): 6.16% Revenue Growth (next year): 2.57%

AI-Powered RDY Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 75.50%
75.50%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Dr. Reddy's Laboratories Ltd News

RDY Breaking Stock News: Dive into RDY Ticker-Specific Updates for Smart Investing

All RDY News

Share on Social Networks: